|
Noel Hall co-founded Aspreva following more than 20 years experience in the pharmaceutical industry. Prior to establishing Aspreva, Mr. Hall founded the Life Sciences Practice of Hill and Knowlton and led the firm's global strategic planning for the worldwide pharmaceutical practice.
Throughout his career, Mr. Hall has worked closely with specialty pharmaceutical companies on their commercialization and pharmaceutical partnering initiatives. His experience allows him to successfully lead the highly specialized integrated medical and commercialization programs required for rare disease product development. He has counselled many of the world's leading pharmaceutical companies on various issues including commercial assessment, pre-approval market development, product positioning, strategic planning, pre and post launch marketing, medical education, stakeholder management, public relations, market access and product reimbursement.
Mr. Hall currently serves as a director of the Canadian Genetics Diseases Network. | 